John Oyler, BeiGene CEO (Paul Yeung/Bloomberg via Getty Images)

BeiGene will re­brand to BeOne Med­i­cines, drop­ping name's link to Chi­na roots

The glob­al phar­ma com­pa­ny whose name rhymes with the cap­i­tal of Chi­na wants peo­ple to know that it is not in fact a Chi­nese com­pa­ny …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.